Related Experiment Video
Updated: Aug 4, 2026
11:12
Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat
Published on: February 7, 2011
Insulin resistance: definition and consequences
1State University of New York Health Science Center at Brooklyn, USA. hlebovitz@attglobal.net
Summary
Insulin resistance, a key factor in type 2 diabetes, involves impaired glucose uptake due to issues in insulin signaling pathways. Understanding its causes, like genetic factors and obesity, is crucial for potential disease definition and treatment.
Area of Science:
- Biochemistry
- Endocrinology
- Metabolic Diseases
Background:
- Insulin resistance is defined as reduced glucose uptake and utilization by insulin.
- Insulin action involves two distinct intracellular signaling pathways: one for metabolism and one for growth.
- These pathways can be dissociated, with metabolic pathways potentially impaired in type 2 diabetes.
Purpose of the Study:
- To explore the mechanisms underlying insulin resistance and the insulin resistance syndrome.
- To discuss potential causes including genetic abnormalities, fetal malnutrition, and visceral adiposity.
- To consider whether insulin resistance should be classified as a distinct disease entity.
Main Methods:
- Review of existing literature on insulin action and resistance.
- Analysis of proposed mechanisms contributing to insulin resistance.
- Conceptual discussion on disease definition and treatment implications.
Main Results:
- Insulin resistance impairs glucose metabolism through specific signaling cascades.
- Potential causes include genetic factors, fetal malnutrition, and increased visceral fat.
- Insulin resistance is linked to cardiovascular-metabolic abnormalities (Metabolic Syndrome).
Conclusions:
- The distinct roles of metabolic and growth pathways in insulin action are highlighted.
- Insulin resistance is associated with serious health conditions like type 2 diabetes and hypertension.
- The definition and therapeutic approach to insulin resistance warrant further consideration.
More Related Videos
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.